Caspersen, Nina F.
Røsjø, Helge
Flyvbjerg, Allan
Bjerre, Mette
Randby, Anna
Hrubos-Strøm, Harald
Omland, Torbjørn
Einvik, Gunnar
Funding for this research was provided by:
South-Eastern Norway Regional Health Authority (2004219,2007048)
Extrastiftelsen in collaboration with the Norwegian Heart and Lung Association (2015/F07781)
Article History
Received: 16 October 2017
Accepted: 20 March 2018
First Online: 2 April 2018
Ethics approval and consent to participate
: The study was conducted in accordance with the amended Declaration of Helsinki, and the Regional Committee for Medical Research Ethics in Eastern Norway approved the protocol (1.2005.839). We obtained written informed consent from all participants prior to study commencement.
: Not applicable
: TO has received speaker and/or consultancy honoraria from Abbott Diagnostics, Roche Diagnostics, Novartis and research support from Abbott Diagnostics, AstraZeneca, Thermo Fisher Scientific, and Biomedica. GE has received research grants from Astra Zeneca and speaker honorarium from Takeda. The other authors declare no reported conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.